Better Buy: Veeva Systems vs. HubSpot
Veeva Systems (NYSE: VEEV) and HubSpot (NYSE: HUBS) both simplify tasks for companies with their cloud-based services. Veeva provides customer relationship management (CRM), storage, analytics, and other tools to life science companies. Its services also keep track of clinical trials and industry regulations.
HubSpot bundles together CRM, marketing, lead generation, search engine optimization, and analytics tools in an all-in-one package. It mainly specializes in "inbound" marketing campaigns that encourage consumers to seek out brands on their own. HubSpot serves more industries than Veeva, and its platform is generally simpler and cheaper to operate than larger CRM platforms like salesforce.com (NYSE: CRM).
Veeva and HubSpot aren't direct competitors, but both companies have generated multibagger gains in just a few years. Veeva went public at $20 per share in 2013 and now trades at about $270. HubSpot went public in 2015 at $25 per share and is now trading around $460.
Source Fool.com
